Vancouver, BC, April 09, 2026 (GLOBE NEWSWIRE) — Big Bear Gold Corp. (TSXV: BEAR) (the “Company”) wishes to announce the results of its 2026 annual general meeting of shareholders (the “2026 AGM”) held on April 6, 2026.  Shareholders voted in favour of all matters brought before the meeting, including re-appointing Davidson & Company LLP, as the Company’s auditor and approving the Company’s new Omnibus Long-Term Incentive Plan (the “Omnibus Plan”).  In addition, Peter Laipnieks, Corey Klassen, Allen Schwabe and Matt Wayrynen were all re-elected as directors of the Company. The Omnibus Plan provides the Company with a variety of security-related mechanisms to attract, retain, and motivate qualified directors, employees, and consultants.  The Omnibus Plan replaced the Company’s prior stock option plan and includes (i) a 10% “rolling”...

Fully permitted for diamond drilling on niobium and rare earth targets at Seigneurie, Bardy and Blanchette Vancouver, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) — North American Niobium and Critical Minerals Corp. (CSE: NIOB) (FSE: KS82.F) (OTCQB: NIOMF) (“NIOB” or the Company) can launch maiden diamond drill programs at Bardy and Blanchette, after receiving an Authorization for Impact-Causing Exploration Work (ATI) for each project. Granted by Québec’s Ministère des Ressources naturelles et des Forêts (MRNF), the ATI authorizes the Company to proceed with diamond drilling targeting niobium and rare earth element mineralization at the 100% owned projects located approximately 45 km northwest of La Tuque in the Mauricie region. “We are now authorized to drill at three of our 100% owned projects in Québec: Bardy, Blanchette,...

JENA, Germany, April 09, 2026 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced new in vitro findings demonstrating that izicopan does not exhibit time-dependent inhibition of CYP3A4, an important indicator for the risk for drug-drug interactions (DDIs) and liver toxicity. These results further support izicopan’s potential as a differentiated, best-in-class oral C5a receptor (C5aR) inhibitor. To build upon previous CYP interaction data for izicopan, which showed only marginal inhibition of CYP3A4 (IC₅₀ = 62 µM) in a time-dependent inhibition (TDI) IC₅₀ shift assay, InflaRx conducted a mechanistically informative Ki-based TDI (Ki/Kinact) study. While TDI shift assays serve as rapid screening tools to identify potential...

Signing of Second Long-Term Agreement with Major Aerospace and Defense Customer in 2026, Demonstrating Continued Customer Confidence and Contract Momentum NEWPORT BEACH, Calif., April 09, 2026 (GLOBE NEWSWIRE) — AGA Precision Systems LLC (“AGA”), an ITAR-registered and AS9100-certified precision CNC aerospace and defense manufacturing company and subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), today announced the execution of a Long-Term Agreement (“LTA”) with globally recognized Tier 1 aerospace and defense company. The LTA formalizes an ongoing multi-year supplier-customer relationship and governs future purchase orders issued during its term. This marks AGA’s second long-term agreement with an aerospace and defense customer, following the execution of an LTA with Turbo-Jet Products Co., Inc. announced March 31, 2026, and reflects...

MONTREAL, April 09, 2026 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the first quarter of 2026 on April 30, 2026. That same day, Bombardier will hold its Annual General Meeting of Shareholders (“Meeting”) in a virtual format. Financial results for the first quarter of 2026 Éric Martel, President and Chief Executive Officer, Bombardier, and Bart Demosky, Executive Vice President and Chief Financial Officer, Bombardier, will present the financial results for the first quarter of 2026 in a live presentation, followed by a question-and-answer period with analysts. The presentation will take place on April 30, 2026, at 8:00 a.m. ET. To listen in:Live webcast (recommended):A live webcast of the financial results presentation, along with the relevant financial charts, will be available on this webpage.By...

Initial Southern California deployment marks next phase of national retail expansion LAS VEGAS, April 09, 2026 (GLOBE NEWSWIRE) — Bitcoin Bancorp, Inc. (OTC: BCBC) (“Bitcoin Bancorp” or the “Company”), the holder of foundational patents for Bitcoin ATMs, and one of only three publicly traded Bitcoin ATM network owner/operators, today announced the initial deployment of licensed Bitcoin ATMs in Southern California. The Company has completed its first installations in the greater Los Angeles area, marking the next phase of its national expansion strategy. This move follows its previously announced rollout in Texas and represents continued execution of a broader plan to scale its Bitcoin ATM network across key U.S. retail markets. The Bitcoin ATM industry continues its rapid expansion, with the U.S. crypto ATM market valued at approximately...

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced the following updates to the composition of its Board of Directors’ standing committees following the appointments of Lisa Gavales and Sue Gove as independent directors:Audit Committee: Gene Davis (Chair), Sue Gove, Carney Hawks and Nikolaj Sjoqvist; Compensation and Benefits Committee: Carney Hawks (Chair), Gene Davis and Lisa Gavales; Nominating and Corporate Governance Committee: Nikolaj Sjoqvist (Chair), Gene Davis and Sue Gove; and Strategy and Finance Committee: Gene Davis (Chair), Lisa Gavales, Carney Hawks, Mike Mason and Nikolaj Sjoqvist.Office of the CEO UpdateAs previously announced, the Board established a Transition Committee...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES (Note: All dollar amounts in this news release are expressed in U.S. dollars except as otherwise noted.) TORONTO, April 09, 2026 (GLOBE NEWSWIRE) — Fairfax India Holdings Corporation (“Fairfax India” or the “Company”) (TSX: FIH.U) announces that its wholly-owned subsidiary, FIH Mauritius Investments Ltd has sold 1,742,987 equity shares, representing its entire equity interest, in Sanmar Chemical Enterprises Limited (“SCEL”) to an affiliate of SCEL for INR 2,480 million (approximately US$27 million at current exchange rates). Following the sale, Fairfax India has no economic interest in SCEL. About Fairfax India Fairfax India is an investment holding company whose objective is to achieve long term capital appreciation, while preserving capital,...

KUALA LUMPUR, April 09, 2026 (GLOBE NEWSWIRE) — WF Holding Limited (the “Company”) (NASDAQ: WFF), a Malaysia-based manufacturer of fiberglass reinforced plastic products, today announced that the shareholders and the board of directors of the Company approved a one-for-five reverse share split of the Company’s issued and unissued ordinary shares. Beginning April 13, 2026, the Company’s ordinary shares will be trading on a split-adjusted basis under the same symbol “WFF” but with a new CUSIP number, G9627R115, and a new par value of $0.00025 per share. As a result of the reverse share split, each five (5) ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of shareholders. No fractional shares will be issued as a result of the reverse share...

BMC Psychiatry publication reports statistically significant reductions in self-injury behaviors and depressive symptoms, with brain-network findings further supporting Nexalin’s differentiated, non-invasive DIFS approach Publication adds to Nexalin’s growing body of peer-reviewed evidence across insomnia and depression, TBI and PTSD, Alzheimer’s disease and ADHD Houston, TX, April 09, 2026 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced another publication of a peer-reviewed study in BMC Psychiatry reporting that Nexalin’s DIFS 77.5 Hz high-gamma approach was associated with statistically significant reductions in self-injury behaviors and depressive symptoms in female adolescents with non-suicidal...